DocuSign (DOCU)

DocuSign (DOCU) Income Statement


DocuSign Income Statement

Last quarter (Q1 2025), DocuSign's total revenue was $709.64M, an increase of 11.00% from the same quarter last year. In Q1, DocuSign's net income was $-108.74M. See DocuSign’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Jan 24Jan 23Jan 22Jan 21Jan 20
Total Revenue
$ 2.81B$ 2.76B$ 2.52B$ 2.11B$ 1.45B$ 973.97M
Cost of Revenue
$ 585.58M$ 572.62M$ 536.09M$ -466.45M$ 364.06M$ 243.23M
Gross Profit
$ 2.22B$ 2.19B$ 1.98B$ 1.64B$ 1.09B$ 730.74M
Operating Expense
$ 2.24B$ 2.13B$ 2.07B$ -1.70B$ 1.26B$ 924.25M
Operating Income
$ -12.21M$ 31.63M$ -88.03M$ -470.43M$ -173.85M$ -193.51M
Net Non Operating Interest Income Expense
$ -39.61M$ -62.05M$ -6.39M$ -5.03M$ -21.89M$ -13.04M
Other Income Expense
$ 44.14M$ -30.38M$ -4.54M$ -778.80M$ -33.75M$ 2.99M
Pretax Income
$ -27.06M$ 93.68M$ -89.88M$ -66.91M$ -229.49M$ -203.56M
Tax Provision
$ 17.44M$ 19.70M$ 7.57M$ 3.06M$ 13.78M$ 4.80M
Earnings From Equity Interest Net Of Tax
Net Income Common Stockholders
$ -346.43M$ 73.98M$ -636.18M$ -478.52M$ -243.27M$ -208.36M
Basic EPS
$ 0.52$ 0.36$ -0.49$ -0.36$ -1.31$ -1.18
Diluted EPS
$ 0.52$ 0.36$ -0.49$ -0.36$ -1.31$ -1.18
Basic Average Shares
$ 819.52M$ 204.07M$ 200.90M$ 196.68M$ 185.76M$ 176.70M
Diluted Average Shares
$ 837.63M$ 208.95M$ 200.90M$ 196.68M$ 185.76M$ 176.70M
Dividend Per Share
Total Operating Income As Reported
Reported Normalized Basic E P S
----$ 0.98$ 0.33
Reported Normalized Diluted E P S
----$ 0.90$ 0.31
Rent Expense Supplemental
Total Expenses
$ 2.82B$ 2.70B$ 2.60B$ -2.17B$ 1.63B$ 1.17B
Net Income From Continuing And Discontinued Operation
$ -44.51M$ 73.98M$ -97.45M$ -478.52M$ -243.27M$ -208.36M
Normalized Income
$ 49.90M$ 218.42M$ 496.06M-$ -218.63M$ -207.65M
Interest Expense
----$ 30.80M$ 27.28M
$ 12.55M$ 100.52M$ -83.49M$ -60.47M$ -198.69M$ -176.28M
$ 111.87M$ 195.59M$ 7.73M$ 26.54M$ -127.60M$ -126.10M
Currency in USD

DocuSign Earnings and Revenue History

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis